Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study

Psychiatry Clin Neurosci. 2000 Feb;54(1):37-40. doi: 10.1046/j.1440-1819.2000.00634.x.

Abstract

The effects of zolpidem and zopiclone, non-benzodiazepine ultra-short-acting hypnotics, on cognitive function and vigilance level were investigated in the morning following nocturnal administration using event-related potentials (ERP) and a sleep latency test (SLT). Zopiclone significantly shortened the sleep latency the following morning, whereas zolpidem did not, perhaps due to the difference in the elimination half-lives between the compounds. No significant effect was observed for either drug on the ERP indices, including the P3, mismatch negativity and negative difference components. At a clinically prescribed dosage these sleep inducers have no remarkable effect on cognitive or attentional functions but increase sleepiness of the subjects.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Attention / drug effects*
  • Azabicyclo Compounds
  • Cognition / drug effects*
  • Cross-Over Studies
  • Double-Blind Method
  • Event-Related Potentials, P300 / drug effects
  • Female
  • Half-Life
  • Humans
  • Hypnotics and Sedatives / administration & dosage
  • Hypnotics and Sedatives / pharmacokinetics
  • Hypnotics and Sedatives / pharmacology*
  • Male
  • Piperazines / pharmacology*
  • Placebos
  • Pyridines / administration & dosage
  • Pyridines / pharmacokinetics
  • Pyridines / pharmacology*
  • Zolpidem

Substances

  • Azabicyclo Compounds
  • Hypnotics and Sedatives
  • Piperazines
  • Placebos
  • Pyridines
  • zopiclone
  • Zolpidem